Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.
about
Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and SafetyPediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Management of cardiovascular complications in systemic lupus erythematosus.Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United StatesHydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.Cardiovascular involvement in autoimmune diseases.New therapeutic targets for the antiphospholipid syndrome.Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohortHydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases.A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosusAntiphospholipid Syndrome during pregnancy: the state of the artAmerican College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisGenetic risk factors for thrombosis in systemic lupus erythematosus.Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) studyPharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC-MS/MS.Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.Pregnancy and autoimmune connective tissue diseasesAssociation between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort studyCardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis.Thrombosis in systemic lupus erythematosus: risk and protection.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?The role of antimalarial agents in the treatment of SLE and lupus nephritis.Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Platelets and autoimmunity.The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus.Top 10 clinical research developments in antiphospholipid syndrome.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Pathogenesis and treatment of atherosclerosis in lupus.Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.Vaccination of patients with autoimmune inflammatory rheumatic diseases.Lupus Anticoagulant Positivity in Pediatric Patients With Prolonged Activated Partial Thromboplastin Time: A Single-Center Experience and Review of Literature.Emerging Therapies in Antiphospholipid Syndrome.
P2860
Q33414595-071F5E4F-7EFA-442C-B048-0F1F574649DFQ33422958-67C9804C-6D9C-423A-A448-0004EC1AC4D3Q33692770-355E70B2-E4A6-4732-B6A0-71EAB4B77DBBQ33723511-9567A61C-0C03-47F2-8D05-50664F611E96Q33730536-FA4E33C5-F56D-4D0E-934A-A22AA7473B6DQ33747286-A6F53571-0207-421F-8A85-FF1AB53FC1FDQ33945242-925EBB14-5DB9-4A7B-92C0-5A159E10D9DEQ34003992-9774B8A4-8B96-4705-8909-58990E3DBDC8Q34081242-BB20B560-4250-4B19-8C7A-1AB7AA86CC66Q34140319-13BBBDF4-0DFF-4F6E-8CD8-3D312ABAE9F4Q34161393-4648EA32-F5B3-4642-BE91-43B45BEB8A1EQ34162739-34467521-EAF4-4CE4-823F-186FAF94D1BBQ34392922-BE731307-128F-44B1-A401-0FBA5B217037Q34722499-6EE751BB-D878-482B-87D4-8397D63DD206Q35686616-6A6CBFD6-A678-4AC1-8E22-F3E443AE8612Q35756040-946D9DD8-D155-4441-8E15-47DC657277EDQ36221407-6B44C4F4-849F-41D9-A2C7-E1790D44D253Q36807470-C9DD1486-6A7C-45E3-8F1B-E079690E4E8CQ36937161-00388D34-FBBE-4637-A433-D72097ECEB8AQ36942997-972E847D-F5C8-4196-ACDF-B64FCA99642BQ37033345-398C4B8C-EEE2-421D-81DE-C6E26608BB32Q37100267-29ABF7F0-8290-483D-8AF2-7EF20005A188Q37228076-A081B891-AEDA-4C0B-89FE-4A4E6C6297D5Q37330468-C713F364-7C52-4632-8DB4-60F3B964E97CQ37398046-4FDA026B-5FBF-47A0-A596-0B773D53D0FCQ37642828-BB20F248-380F-4D46-AA2E-A88D10E75840Q37721617-5E802EF0-A118-4DB1-85DC-54602C646571Q37947108-FEE3A2FD-9D03-4FC8-83B2-1121F617E9F2Q38009852-9E73F05E-76F2-4DC6-AC8A-F96750566341Q38026787-4020C261-FE81-4801-9645-23050916E2E9Q38101015-EBECB5EC-D213-4163-A8C0-2CF67F090786Q38101678-CFFB34D1-166A-4874-A57D-62994F7A2ADCQ38125246-C504DD09-CC16-4331-BC57-A2D71D7D9D4EQ38135335-C04B1624-0728-4B7C-84A2-F236BB3AC8B8Q38162490-B1F0045C-4AA6-44B8-A7BC-39855A66D357Q38230699-BA8AFC71-90BA-42B9-9968-B28DA917EE34Q38241501-B3376C36-AE57-4CED-96C5-C900E67C3DC1Q38285275-BA9B3687-3EF9-47FB-89CA-AB304431DD95Q38588960-EE0DA3E3-F3FD-4378-B9B5-8F8B5E11F526Q38782057-25D6EBB4-1CF7-4502-9F40-DB17E7649632
P2860
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@ast
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@en
type
label
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@ast
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@en
prefLabel
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@ast
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@en
P2093
P2860
P356
P1476
Risk and protective factors fo ...... a large, multi-ethnic cohort.
@en
P2093
C M Cleveland
L A Criswell
P2860
P304
P356
10.1136/ARD.2008.093013
P407
P577
2008-09-09T00:00:00Z